Akso Health Group Sponsored ADR (NASDAQ:AHG - Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 161,604 shares traded hands during mid-day trading, an increase of 91% from the previous session's volume of 84,661 shares.The stock last traded at $2.2780 and had previously closed at $2.31.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a "sell (d-)" rating on shares of Akso Health Group in a report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of "Sell".
Read Our Latest Analysis on Akso Health Group
Akso Health Group Stock Performance
The business has a 50 day moving average of $1.98 and a 200-day moving average of $1.67.
Institutional Investors Weigh In On Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC bought a new stake in Akso Health Group Sponsored ADR (NASDAQ:AHG - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 16,748 shares of the company's stock, valued at approximately $27,000. 1.21% of the stock is owned by hedge funds and other institutional investors.
About Akso Health Group
(
Get Free Report)
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Akso Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Akso Health Group wasn't on the list.
While Akso Health Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.